Hydroxyzine Should Not Be Used in Patients with Active Psychotic Disorders
Hydroxyzine is contraindicated in patients with active psychosis due to its anticholinergic properties that can worsen psychotic symptoms, its potential to cause QT prolongation when combined with antipsychotics, and lack of any antipsychotic efficacy. 1, 2
Why Hydroxyzine is Problematic in Psychosis
Worsening of Psychotic Symptoms
Hydroxyzine has significant anticholinergic properties that can directly exacerbate psychotic symptoms. The 2016 Pediatrics guideline explicitly warns that "because of their anticholinergic properties, antipsychotics may worsen the condition of patients who present with intoxication from drugs with anticholinergic properties (eg, hallucinogens) or with an anticholinergic delirium" 1. This same mechanism applies to hydroxyzine—adding an anticholinergic agent like hydroxyzine to a patient already experiencing psychosis can intensify hallucinations, delusions, and confusion.
Dangerous Drug Interactions with Antipsychotics
The FDA label for hydroxyzine explicitly warns about QT prolongation and lists antipsychotics as medications requiring caution when used concomitantly 2. The 2016 Pediatrics guideline specifically identifies hydroxyzine as a QT-interval-prolonging medication 1, and when combined with antipsychotics (which also prolong QT intervals), this creates a compounded risk for life-threatening cardiac arrhythmias including torsades de pointes.
The FDA label states: "Caution is recommended during the concomitant use of drugs known to prolong the QT interval. These include...certain antipsychotics (e.g., ziprasidone, iloperidone, clozapine, quetiapine, chlorpromazine)" 2.
No Role in Psychosis Treatment
Hydroxyzine is an antihistamine indicated for anxiety and allergic conditions 2, 3, 4. The treatment guidelines for psychotic disorders consistently recommend antipsychotic medications as the definitive treatment 5, 6. There is no evidence supporting hydroxyzine's use for treating psychotic symptoms themselves.
When Hydroxyzine Might Be Considered (Limited Scenarios)
The only potential role for hydroxyzine in patients with psychotic disorders would be:
As an adjunct for acute agitation in emergency settings: The 2016 Pediatrics guideline mentions combinations like "risperidone + diphenhydramine" for chemical restraint 1. However, note this uses diphenhydramine (not hydroxyzine specifically) and only in acute emergency situations where the patient requires immediate sedation, not as ongoing treatment.
For comorbid anxiety after psychosis is controlled: Only after psychotic symptoms are stabilized on antipsychotics, and only if the anticholinergic burden and QT prolongation risk are carefully monitored 3, 4.
Critical Clinical Pitfalls to Avoid
Never use hydroxyzine as monotherapy for psychosis—it has no antipsychotic properties and will allow the psychotic disorder to progress untreated.
Avoid combining hydroxyzine with antipsychotics in routine practice due to additive QT prolongation risk, especially in patients with pre-existing cardiac conditions, electrolyte abnormalities, or taking other QT-prolonging medications 2.
Be particularly cautious in elderly patients with psychosis, as they are more susceptible to anticholinergic side effects including confusion, falls, and cognitive impairment 2.
Monitor for paradoxical CNS stimulation if hydroxyzine is used, as this can worsen agitation 7.
The Correct Approach to Psychosis
Treatment of primary psychosis requires antipsychotic medications 5, 8, 9. The 2020 APA guideline states: "APA recommends (1A) that patients with schizophrenia be treated with an antipsychotic medication and monitored for effectiveness and side effects" 5.
For secondary psychosis, treatment targets the underlying medical cause while controlling psychotic symptoms with antipsychotics 8, 9.
Hydroxyzine has no place in this treatment algorithm and poses more risks than benefits when psychotic symptoms are present.